<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gupta R</submitter><funding>HHS | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>C762-C768</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8993518</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>322(4)</volume><pubmed_abstract>The tumor microenvironment (TME) composed of different types of cells embedded in extracellular matrix (ECM) has crucial effects on cancer growth and metastasis. ECM is made of a variety of proteins that provide structural support to the cells and regulate biological functions by modulating the cross talk among cells, thus effecting tumor growth and progression. In this mini-review, the author discusses epigenetic modifications that regulate the expression of fibrous ECM proteins and glycoproteins and the prospects of targeting them for cancer therapy.</pubmed_abstract><journal>American journal of physiology. Cell physiology</journal><pubmed_title>Epigenetic regulation and targeting of ECM for cancer therapy.</pubmed_title><pmcid>PMC8993518</pmcid><funding_grant_id>R01CA233481</funding_grant_id><funding_grant_id>R03CA230815</funding_grant_id><funding_grant_id>R03 CA230815</funding_grant_id><funding_grant_id>R01 CA233481</funding_grant_id><funding_grant_id>R03 CA248913</funding_grant_id><funding_grant_id>R03CA248913</funding_grant_id><pubmed_authors>Gupta R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic regulation and targeting of ECM for cancer therapy.</name><description>The tumor microenvironment (TME) composed of different types of cells embedded in extracellular matrix (ECM) has crucial effects on cancer growth and metastasis. ECM is made of a variety of proteins that provide structural support to the cells and regulate biological functions by modulating the cross talk among cells, thus effecting tumor growth and progression. In this mini-review, the author discusses epigenetic modifications that regulate the expression of fibrous ECM proteins and glycoproteins and the prospects of targeting them for cancer therapy.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-26T13:09:23.428Z</modification><creation>2025-04-06T14:10:53.388Z</creation></dates><accession>S-EPMC8993518</accession><cross_references><pubmed>35235427</pubmed><doi>10.1152/ajpcell.00022.2022</doi></cross_references></HashMap>